Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
carbamazepine epoxide | active carbamazepine metabolite measured separately by some assays | The carbamazepine epoxide result is listed separately from the parent level. | Objective | Drug levels - named analytes and exposure reports |
carboxyhemoglobin fraction | proportion of hemoglobin bound to carbon monoxide | The carboxyhemoglobin fraction was documented with the time since the reported exposure. | Objective | Hematology and transfusion laboratory reporting |
caregiving responsibilities | practical care the patient provides to another person | The patient reports caregiving responsibilities that affect the timing of follow-up visits. | Subjective | Activities, exposure and recovery history |
chelation interaction | drug binds a metal ion and may become less available for absorption | The chelation interaction was considered after the mineral supplement schedule changed. | Assessment | Medication response, exposure and reconciliation |
class effect | effect shared by drugs within a pharmacologic group | Class effect was considered when the symptom recurred with a second drug in the same group. | Assessment | Medication response, exposure and reconciliation |
clearance estimate | calculated ability to eliminate drug per unit time | The clearance estimate depends on the sampling times entered. | Assessment | Drug levels - exposure and pharmacokinetics |
clinical correlation | interpret laboratory or test data together with symptoms and examination | The isolated laboratory flag requires clinical correlation with the current findings. | Assessment | Medication exposure, response and adverse-effect reasoning |
clinically relevant | has a bearing on the current care decision | The prior reaction is clinically relevant to the proposed re-exposure. | Assessment | Risk, goals, medication assessment and function |
clozapine | antipsychotic whose concentration may be reported with its metabolite | The laboratory reports clozapine and norclozapine as separate analytes. | Objective | Drug levels - named analytes and exposure reports |
| maximum concentration in the specified concentration-time profile | The model's Cmax is listed separately from the single timed sample. | Assessment | Drug levels - exposure and pharmacokinetics | |
| minimum concentration in the specified concentration-time profile | The modeled Cmin corresponds to the end of the stated interval. | Assessment | Drug levels - exposure and pharmacokinetics | |
coincided | occurred at the same time | Reports that the first headache coincided with a night shift. | Subjective | Sequence, exposures and use of medicines |
community mobility restriction | difficulty moving about outside the home | The patient reports community mobility restriction because the nearest bus stop is beyond current walking distance. | Subjective | Activities, exposure and recovery history |
competing explanation | another cause that could account for the same change | The intercurrent illness remains a competing explanation for the nausea. | Assessment | Medication exposure, response and adverse-effect reasoning |
concentration-dependent | effect varies with the concentration achieved | The pharmacology review describes concentration-dependent activity. | Assessment | Drug levels - exposure and pharmacokinetics |
concentration-time profile | sequence of concentrations linked to actual sampling times | The concentration-time profile was reconstructed using the medication record and sample labels. | Assessment | Drug concentrations, exposure and assay interpretation |
concentration trend reversal | serial measured levels change direction after an earlier rise or fall | Concentration trend reversal was reviewed alongside the administration timeline. | Assessment | Medication response, exposure and reconciliation |
context-sensitive half-time | time for concentration to fall by half after stopping an infusion of a specified duration | The context-sensitive half-time was interpreted in the context of the prolonged infusion. | Assessment | Drug concentrations, exposure and assay interpretation |
contraindication | condition that makes a treatment inadvisable in context | The documented severe allergy is a contraindication to re-exposure. | Assessment | Medication response and safety |
convergent evidence | independent observations support the same interpretation | The convergent evidence includes the exposure timeline and two repeat measurements. | Assessment | Diagnostic reasoning and strength of evidence |
culture-negative infection | infection remains a clinical consideration despite negative cultures | Culture-negative infection was assessed with prior antimicrobial exposure documented. | Assessment | Infection course, epidemiology and source attribution |
cumulative anticholinergic burden | combined anticholinergic effects from multiple medicines | Cumulative anticholinergic burden was reviewed in relation to the new dry mouth and constipation. | Assessment | Medication response, exposure and reconciliation |
Cutaneous photosensitivity | Photosensitive skin | The patient reports cutaneous photosensitivity after brief sun exposure. | Subjective | Skin, hair and nail symptoms |
cyclosporine | immunosuppressant monitored using a specified timed sampling strategy | The cyclosporine report specifies whether the order was for a predose or two-hour sample. | Objective | Drug levels - named analytes and exposure reports |
| change after a suspect medicine is stopped or reduced | Nausea improved during dechallenge as documented in the medication history. | Assessment | Medication exposure, response and adverse-effect reasoning |